Key facts
- It has raised $1.0M; the latest was Grant ($2.4M) in Sep 2025.
- Notable investors include Australian Government's Department of Health.
- Status: Privately Held (backing).
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Ceretas
- ·The full record, as it builds
Funding rounds
No funding rounds for Ceretas are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ceretas
Operator of a medical device company intended for developing therapeutic ultrasound technologies. The company's device stimulates neural circuits to enhance brain function, providing an alternative to traditional neuromodulation techniques that require surgery or cannot target the deeper brain regions, enabling clients to address neurological illnesses such as Alzheimer's disease.
- Sector
- Healthcare
- HQ
- Australia
- Founded
- 2024
- Employees
- 9
- Website
- ceretas.com.au/
- Ownership
- Privately Held (backing)
Ceretas doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ceretas shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ceretas in its N-PORT filings yet. We sweep new filings monthly.